INSIDER
Eli Lilly granted emergency use authorization for COVID-19 antibody therapy
Read full article: Eli Lilly granted emergency use authorization for COVID-19 antibody therapyDETROIT – There has been some positive news in the search for a coronavirus (COVID-19) treatment. Eli Lilly has been granted emergency use authorization for its monoclonal antibody therapy. It’s similar to the drug by Regeneron that was used to treat President Donald Trump. Eli Lilly’s monoclonal antibody treatment for COVID-19 has authorization to treat mild to moderate COVID-19 in patients who are not hospitalized but are at high risk. The drug is an artificially produced antibody that neutralizes the spike protein on the SARS-CoV-2 virus.